TGFβ-1 expression was seen in 12% of eosinophils in refractory IBD while 48% of eosinophils expressed TGFβ-1 in active responsive IBD and 45% in quiescent IBD (Fig. 6I). This evidence concerns the gene TGFB1 and inflammatory bowel disease.